Regulation of transcription and chromatin structure by pRB: Here, there and everywhere

Cell Cycle

Volumn 11, Issue 17, 2012, Pages 3189-3198

  Talluri, Srikanth ^a   Dick, Frederick A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cell cycle; Chromatin; Condensin; Differentiation; E2F; Retinoblastoma; Senescence; Transcription

Indexed keywords

BRG1 PROTEIN; BRM PROTEIN; CCAAT ENHANCER BINDING PROTEIN; HISTONE DEACETYLASE; HISTONE METHYLTRANSFERASE; MYOD PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; APOPTOSIS; BONE DEVELOPMENT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN CONDENSATION; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CHROMOSOME; DNA DAMAGE; DNA REPLICATION; GENE EXPRESSION; GENOME; HETEROCHROMATIN; HISTONE ACETYLATION; HUMAN; LONG INTERSPERSED REPEAT; MUSCLE DEVELOPMENT; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SENESCENCE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 84866274926     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21263     Document Type: Review

References (107)

1. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002; 2:910-7; PMID:12459729; http://dx.doi.org/10. 1038/nrc950.
2. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002; 2:103-12; PMID:12204530; http://dx.doi.org/10.1016/S1535-6108(02)00102-2.
3. Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-7; PMID:8939849; http://dx.doi.org/10.1126/science.274.5293.1672.
4. Mulligan G, Jacks T. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 1998; 14:223-9; PMID:9635405; http://dx.doi.org/10.1016/S0168-9525(98)01470-X.
5. Dick FA. Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts? Cell Div 2007; 2:26; PMID:17854503; http://dx.doi.org/10.1186/1747-1028-2-26.
6. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998; 12:2245-62; PMID:9694791; http://dx.doi.org/10.1101/gad.12.15.2245.
7. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3:11-20; PMID:11823794; http://dx.doi.org/10.1038/nrm714.
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70; PMID:10647931; http://dx.doi.org/10.1016/S0092-8674(00)81683-9.
9. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334:124-9; PMID:2968522; http://dx.doi.org/10.1038/334124a0.
10. Whyte P, Williamson NM, Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell 1989; 56:67-75; PMID:2521301; http://dx.doi.org/10.1016/0092-8674(89)90984-7.
11. Hamel PA, Gill RM, Phillips RA, Gallie BL. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol 1992; 12:3431-8; PMID:1385853.
12. Weintraub SJ, Prater CA, Dean DC. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 1992; 358:259-61; PMID:1321348; http://dx.doi.org/10.1038/358259a0.
13. Weintraub SJ, Chow KNB, Luo RX, Zhang SH, He S, Dean DC. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 1995; 375:812-5; PMID:7596417; http://dx.doi.org/10.1038/375812a0.
14. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998; 391:601-5; PMID:9468140; http://dx.doi.org/10.1038/35410.
15. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998; 391:597-601; PMID:9468139; http://dx.doi.org/10.1038/35404.
16. Luo RX, Postigo AA, Dean DC. Rb interacts with histone deacetylase to repress transcription. Cell 1998; 92:463-73; PMID:9491888; http://dx.doi. org/10.1016/S0092-8674(00)80940-X.
17. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WGJ Jr. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 2005; 18:623-35; PMID:15949438; http://dx.doi.org/10.1016/j.molcel.2005.05.012.
18. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 2000; 25:338-42; PMID:10888886; http://dx.doi.org/10.1038/77124.
19. Dunaief JL. RB and BRG1 form a complex and cooperate to induce mitotic arrest. Diss Abstr Int 1994; 55:2087.
20. Singh P, Coe J, Hong W. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 1995; 374:562-5; PMID:7700385; http://dx.doi.org/10.1038/374562a0.
21. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 2001; 412:561-5; PMID:11484059; http://dx.doi.org/10.1038/35087620.
22. Gonzalo S, García-Cao M, Fraga MF, Schotta G, Peters AH, Cotter SE, et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 2005; 7:420-8; PMID:15750587; http://dx.doi.org/10.1038/ncb1235.
23. Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J, et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 2001; 15:2250-62; PMID:11544182; http://dx.doi.org/10.1101/gad.870101.
24. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche D. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol Cell Biol 2001; 21:6484-94; PMID:11533237; http://dx.doi.org/10.1128/MCB.21.19.6484-6494.2001.
25. Isaac CE, Francis SM, Martens AL, Julian LM, Seifried LA, Erdmann N, et al. The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol 2006; 26:3659-71; PMID:16612004; http://dx.doi.org/10.1128/MCB.26.9.3659- 3671.2006.
26. Siddiqui H, Fox SR, Gunawardena RW, Knudsen ES. Loss of RB compromises specific heterochromatin modifications and modulates HP1alpha dynamics. J Cell Physiol 2007; 211:131-7; PMID:17245754; http://dx.doi.org/10.1002/jcp.20913.
27. García-Cao M, Gonzalo S, Dean D, Blasco MA. A role for the Rb family of proteins in controlling telomere length. Nat Genet 2002; 32:415-9; PMID:12379853; http://dx.doi.org/10.1038/ng1011.
28. Narita M, N nez S, Heard E, Narita M, Lin AW, Hearn SA, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-16; PMID:12809602; http://dx.doi.org/10. 1016/S0092-8674(03)00401-X.
29. Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, et al. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 2010; 17:376-87; PMID:20385362; http://dx.doi.org/10. 1016/j.ccr.2010.01.023.
30. Longworth MS, Herr A, Ji JY, Dyson NJ. RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAPD3. Genes Dev 2008; 22:1011-24; PMID:18367646; http://dx.doi.org/10.1101/ gad.1631508.
31. Coschi CH, Martens AL, Ritchie K, Francis SM, Chakrabarti S, Berube NG, et al. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev 2010; 24:1351-63; PMID:20551166; http://dx.doi.org/10.1101/gad.1917610.
32. Helin K, Harlow E, Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993; 13:6501-8; PMID:8413249.
33. Ikeda MA, Nevins JR. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol 1993; 13:7029-35; PMID:8413292.
34. Fattaey AR, Harlow E, Helin K. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol 1993; 13:7267-77; PMID:8246949.
35. Liu X, Marmorstein R. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Genes Dev 2007; 21:2711-6; PMID:17974914; http://dx.doi.org/10.1101/gad.1590607.
36. Bagchi S, Raychaudhuri P, Nevins JR. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 1990; 62:659-69; PMID:2143697; http://dx.doi.org/10.1016/0092-8674(90)90112-R.
37. Whyte P, Ruley HE, Harlow E. Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol 1988; 62:257-65; PMID:2960834.
38. Herrera RE, Sah VP, Williams BO, Mäkelä TP, Weinberg RA, Jacks T. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol 1996; 16:2402-7; PMID:8628308.
39. Hurford RK Jr., Cobrinik D, Lee MH, Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 1997; 11:1447-63; PMID:9192872; http://dx.doi.org/10.1101/gad.11.11. 1447.
40. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993; 72:309-24; PMID:8381715; http://dx.doi.org/10.1016/0092-8674(93)90110-C.
41. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC, et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 2001; 8:303-16; PMID:11545733; http://dx.doi.org/10.1016/S1097-2765(01)00327-6.
42. Chen PL, Riley DJ, Chen-Kiang S, Lee WH. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci USA 1996; 93:465-9; PMID:8552662; http://dx.doi.org/10.1073/pnas.93.1.465.
43. Chen P-L, Riley DJ, Chen Y, Lee W-H. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 1996; 10:2794-804; PMID:8946919; http://dx.doi.org/10.1101/ gad.10.21.2794.
44. MacLellan WR, Xiao G, Abdellatif M, Schneider MD. A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol 2000; 20:8903- 15; PMID:11073990; http://dx.doi.org/10.1128/MCB.20.23.8903-8915.2000.
45. Miyake S, Sellers WR, Safran M, Li X, Zhao W, Grossman SR, et al. Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle. Mol Cell Biol 2000; 20:8889-902; PMID:11073989; http://dx.doi.org/10.1128/MCB.20.23.8889-8902.2000.
46. Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev 1994; 8:1270-84; PMID:7926730; http://dx.doi. org/10.1101/gad.8.11.1270.
47. Lee JS, Thomas DM, Gutierrez G, Carty SA, Yanagawa S, Hinds PW. HES1 cooperates with pRb to activate RUNX2-dependent transcription. J Bone Miner Res 2006; 21:921-33; PMID:16753023; http://dx.doi.org/10.1359/jbmr.060303.
48. Calo E, Quintero-Estades JA, Danielian PS, Nedelcu S, Berman SD, Lees JA. Rb regulates fate choice and lineage commitment in vivo. Nature 2010; 466:1110-4; PMID:20686481; http://dx.doi.org/10.1038/nature09264.
49. Gutierrez GM, Kong E, Sabbagh Y, Brown NE, Lee JS, Demay MB, et al. Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1-/- mice. Proc Natl Acad Sci USA 2008; 105:18402-7; PMID:19020086; http://dx.doi.org/10.1073/pnas.0805925105.
50. Ianari A, Natale T, Calo E, Ferretti E, Alesse E, Screpanti I, et al. Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell 2009; 15:184-94; PMID:19249677; http://dx.doi.org/10.1016/j.ccr.2009.01. 026.
51. Dick FA, Dyson N. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol Cell 2003; 12:639-49; PMID:14527410; http://dx.doi.org/10.1016/ S1097-2765(03)00344-7.
52. Cecchini MJ, Dick FA. The biochemical basis of CDK phosphorylation- independent regulation of E2F1 by the retinoblastoma protein. Biochem J 2011; 434:297-308; PMID:21143199; http://dx.doi.org/10.1042/BJ20101210.
53. Stevens C, Smith L, La Thangue NB. Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol 2003; 5:401-9; PMID:12717439; http://dx.doi.org/10. 1038/ncb974.
54. Carnevale J, Palander O, Seifried LA, Dick FA. DNA damage signals through differentially modified E2F1 molecules to induce apoptosis. Mol Cell Biol 2012; 32:900-12; PMID:22184068; http://dx.doi. org/10.1128/MCB.06286-11.
55. Duronio RJ, O'Farrell PH. Developmental control of the G1 to S transition in Drosophila: cyclin Eis a limiting downstream target of E2F. Genes Dev 1995; 9:1456-68; PMID:7601350; http://dx.doi.org/10.1101/gad.9.12.1456.
56. Duronio RJ, Brook A, Dyson N, O'Farrell PH. E2F-induced S phase requires cyclin E. Genes Dev 1996; 10:2505-13; PMID:8843201; http://dx.doi.org/10.1101/ gad.10.19.2505.
57. Le Cam L, Polanowska J, Fabbrizio E, Olivier M, Philips A, Ng Eaton E, et al. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J 1999; 18:1878-90; PMID:10202151; http://dx.doi.org/10.1093/emboj/18.7.1878.
58. Morrison AJ, Sardet C, Herrera RE. Retinoblastoma protein transcriptional repression through histone deacetylation of a single nucleosome. Mol Cell Biol 2002; 22:856-65; PMID:11784861; http://dx.doi.org/10.1128/MCB.22.3.856-865.2002.
59. Polanowska J, Fabbrizio E, Le Cam L, Trouche D, Emiliani S, Herrera R, et al. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element. Oncogene 2001; 20:4115-27; PMID:11464278; http://dx.doi.org/10.1038/sj.onc.1204514.
60. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, et al. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 2002; 16:933-47; PMID:11959842; http://dx.doi.org/10.1101/gad.969202.
61. Ferreira R, Naguibneva I, Mathieu M, Ait-Si-Ali S, Robin P, Pritchard LL, et al. Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter. EMBO Rep 2001; 2:794-9; PMID:11520855; http://dx.doi.org/10.1093/embo-reports/kve173.
62. Nicolas E, Roumillac C, Trouche D. Balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter. Mol Cell Biol 2003; 23:1614-22; PMID:12588981; http://dx.doi.org/10. 1128/MCB.23.5.1614-1622.2003.
63. Dick FA, Sailhamer E, Dyson NJ. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol Cell Biol 2000; 20:3715-27; PMID:10779361; http://dx.doi.org/10.1128/MCB.20.10.3715-3727.2000.
64. Singh M, Krajewski M, Mikolajka A, Holak TA. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences. J Biol Chem 2005; 280:37868-76; PMID:16118215; http://dx.doi.org/10.1074/jbc. M504877200.
65. Meloni AR, Smith EJ, Nevins JR. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc Natl Acad Sci USA 1999; 96:9574-9; PMID:10449734; http://dx.doi.org/10.1073/ pnas.96.17.9574.
66. Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC, et al. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol 2001; 21:2918-32; PMID:11283269; http://dx.doi.org/10.1128/MCB.21.8.2918-2932.2001.
67. Chinnadurai G. Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol 2007; 39:1593-607; PMID:17336131; http://dx.doi.org/10. 1016/j.biocel.2007.01.025.
68. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 1998; 95:10493-8; PMID:9724731; http://dx.doi.org/10.1073/pnas.95.18.10493.
69. Imbalzano AN, Kwon H, Green MR, Kingston RE. Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature 1994; 370:481-5; PMID:8047170; http://dx.doi.org/10.1038/370481a0.
70. Wang W, Côté J, Xue Y, Zhou S, Khavari PA, Biggar SR, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 1996; 15:5370-82; PMID:8895581.
71. Schnitzler G, Sif S, Kingston RE. Human SWI/SNF interconverts a nucleosome between its base state and a stable remodeled state. Cell 1998; 94:17-27; PMID:9674423; http://dx.doi.org/10.1016/S0092-8674(00)81217-9.
72. Martens JA, Winston F. Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev 2003; 13:136-42; PMID:12672490; http://dx.doi.org/10.1016/S0959-437X(03)00022-4.
73. Ooi L, Belyaev ND, Miyake K, Wood IC, Buckley NJ. BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression. J Biol Chem 2006; 281:38974-80; PMID:17023429; http://dx.doi.org/10. 1074/jbc.M605370200.
74. Strober BE, Dunaief JL, Guha S, Goff SP. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol 1996; 16:1576-83; PMID:8657132.
75. Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, et al. BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 2000; 97:7748-53; PMID:10884406; http://dx.doi.org/10.1073/ pnas.97.14.7748.
76. Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci USA 1997; 94:11268-73; PMID:9326598; http://dx.doi. org/10.1073/pnas.94.21.11268.
77. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J 1998; 17:6979-91; PMID:9843504; http://dx.doi. org/10.1093/emboj/17.23.6979.
78. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 2000; 6:1287-95; PMID:11163203; http://dx.doi.org/ 10.1016/S1097-2765(00)00127-1.
79. Coisy M, Roure V, Ribot M, Philips A, Muchardt C, Blanchard JM, et al. Cyclin A repression in quiescent cells is associated with chromatin remodeling of its promoter and requires Brahma/SNF2alpha. Mol Cell 2004; 15:43-56; PMID:15225547; http://dx.doi.org/10.1016/j.molcel.2004.06.022.
80. Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Bergès J, Helin K, et al. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci USA 1995; 92:11264-8; PMID:7479977; http://dx.doi.org/10.1073/pnas.92.24.11264.
81. Gunawardena RW, Fox SR, Siddiqui H, Knudsen ES. SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B. J Biol Chem 2007; 282:20116-23; PMID:17510060; http://dx.doi.org/10.1074/jbc.M701406200.
82. Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410:120-4; PMID:11242054; http://dx.doi.org/10.1038/ 35065138.
83. Vaute O, Nicolas E, Vandel L, Trouche D. Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases. Nucleic Acids Res 2002; 30:475-81; PMID:11788710; http://dx.doi.org/10.1093/nar/30.2.475.
84. Montoya-Durango DE, Liu Y, Teneng I, Kalbfleisch T, Lacy ME, Steffen MC, et al. Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat Res 2009; 665:20-8; PMID:19427507; http://dx.doi.org/10.1016/j. mrfmmm.2009.02.011.
85. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 2004; 18:1251-62; PMID:15145825; http://dx.doi.org/ 10.1101/gad.300704.
86. Benetti R, Gonzalo S, Jaco I, Schotta G, Klatt P, Jenuwein T, et al. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J Cell Biol 2007; 178:925-36; PMID:17846168; http://dx.doi.org/ 10.1083/jcb.200703081.
87. Bourgo RJ, Siddiqui H, Fox S, Solomon D, Sansam CG, Yaniv M, et al. SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity. Mol Biol Cell 2009; 20:3192-9; PMID:19458193; http://dx.doi. org/10.1091/mbc.E08-12-1224.
88. Ono T, Losada A, Hirano M, Myers MP, Neuwald AF, Hirano T. Differential contributions of condensin I and condensin II to mitotic chromosome architecture in vertebrate cells. Cell 2003; 115:109-21; PMID:14532007; http://dx.doi.org/ 10.1016/S0092-8674(03)00724-4.
89. Hirota T, Gerlich D, Koch B, Ellenberg J, Peters JM. Distinct functions of condensin I and II in mitotic chromosome assembly. J Cell Sci 2004; 117:6435-45; PMID:15572404; http://dx.doi.org/10.1242/jcs.01604.
90. Ono T, Fang Y, Spector DL, Hirano T. Spatial and temporal regulation of Condensins I and II in mitotic chromosome assembly in human cells. Mol Biol Cell 2004; 15:3296-308; PMID:15146063; http://dx.doi.org/10.1091/mbc.E04-03-0242.
91. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22; PMID:15734683; http://dx.doi.org/10.1016/j.cell.2005.02.003.
92. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005; 7:505-12; PMID:15950900; http://dx.doi.org/10.1016/j.ccr.2005.05.025.
93. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436:642; PMID:16079833; http://dx.doi.org/10.1038/436642a.
94. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660-5; PMID:16079837; http://dx.doi.org/10.1038/ nature03841.
95. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233.
96. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogeneinduced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019-31; PMID:18555778; http://dx.doi.org/10.1016/j.cell.2008.03.039.
97. Funayama R, Saito M, Tanobe H, Ishikawa F. Loss of linker histone H1 in cellular senescence. J Cell Biol 2006; 175:869-80; PMID:17158953; http://dx.doi.org/10.1083/jcb.200604005.
98. Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007; 27:2343-58; PMID:17242207; http://dx.doi.org/10.1128/MCB.02019-06.
99. Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22:4212-22; PMID:12912919; http://dx.doi.org/10.1093/emboj/cdg417.
100. Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, et al. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 1997; 15:2589-96; PMID:9399646; http://dx.doi.org/10.1038/ sj.onc.1201446.
101. Sage J, Miller AL, Pérez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 2003; 424:223-8; PMID:12853964; http://dx.doi.org/10.1038/nature01764.
102. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 2000; 14:3037-50; PMID:11114892; http://dx.doi.org/10.1101/gad.843200.
103. Dannenberg J-H, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000; 14:3051-64; PMID:11114893; http://dx.doi.org/10.1101/gad.847700.
104. Talluri S, Isaac CE, Ahmad M, Henley SA, Francis SM, Martens AL, et al. A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol Cell Biol 2010; 30:948-60; PMID:20008551; http://dx.doi.org/10.1128/MCB.01168-09.
105. Chicas A, Kapoor A, Wang X, Aksoy O, Evertts AG, Zhang MQ, et al. H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proceedings of the National Academy of Sciences of the United States of America 2012.
106. Vernier M, Bourdeau V, Gaumont-Leclerc MF, Moiseeva O, Bégin V, Saad F, et al. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 2011; 25:41-50; PMID:21205865; http://dx.doi. org/10.1101/gad.1975111.
107. Narita M, Narita M, Krizhanovsky V, Nuñez S, Chicas A, Hearn SA, et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126:503-14; PMID:16901784; http://dx.doi.org/10.1016/j.cell.2006.05.052.